News for 'drug money'

Gold, Silver Surge Pushes Jan Import Bill Up

Gold, Silver Surge Pushes Jan Import Bill Up

Rediff.com19 Feb 2026

Gold imports climbed 349.22 per cent to $12.07 billion in January, while silver imports rose 127 per cent to $2 billion.

GST cut on drugs, medical devices to help patients

GST cut on drugs, medical devices to help patients

Rediff.com4 Sep 2025

The government's move to cut GST on medicines and medical devices while exempting lifesaving drugs from the levy is a bold step that will bring direct relief to patients and families while significantly reducing financial strain on them, pharmaceuticals and healthcare industry players said on Thursday.

Trump's tariff junked: What it means for Indian companies

Trump's tariff junked: What it means for Indian companies

Rediff.com21 Feb 2026

India will now face a lower reciprocal tariff of 10 per cent, down from 25 per cent, after US President Donald Trump announced a new global levy on items imported into America in the wake of the Supreme Court verdict against his sweeping duties on several nations.

Epstein files: Bill Gates sought pills to treat STD

Epstein files: Bill Gates sought pills to treat STD

Rediff.com31 Jan 2026

Epstein claimed this was due to the consequences of 'sex with Russian girls'.

'CMC govt': Modi launches TN campaign with attack on DMK

'CMC govt': Modi launches TN campaign with attack on DMK

Rediff.com23 Jan 2026

According to the PM, CMC means "Corruption, Mafia, Crime."

At Davos, Trump rules out force to take Greenland, but warns allies

At Davos, Trump rules out force to take Greenland, but warns allies

Rediff.com21 Jan 2026

Trump called for immediate negotiations for the US to acquire Greenland from Denmark, describing the country as ungrateful, during his speech at Davos.

Over 50 held as T'gana's EAGLE Force hits Nigerian cartel's India Ops

Over 50 held as T'gana's EAGLE Force hits Nigerian cartel's India Ops

Rediff.com29 Nov 2025

Telangana's anti-narcotics wing, the EAGLE Force, conducted a multi-state operation against a Nigerian drug cartel, resulting in over 50 arrests and the seizure of narcotics worth Rs 3.5 crore.

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Rediff.com1 Feb 2026

Budget 2026 sticks to fiscal discipline, shuns populist measures despite five key state elections coming up, but ends up rattling stock markets with a higher transaction tax on derivatives trading.

Deaf-mute woman breaks 16-year silence, exposes serial sexual predator

Deaf-mute woman breaks 16-year silence, exposes serial sexual predator

Rediff.com22 Dec 2025

According to the police, the survivor, a resident of Mumbai's western suburbs, communicated in sign language during a video call with her friends and colleagues, who were part of a WhatsApp group, that the accused had drugged and raped her when she was a minor.

A long-game Budget

A long-game Budget

Rediff.com2 Feb 2026

The Union Budget for 2026-27, presented by Finance Minister (FM) Nirmala Sitharaman on Sunday, which was a first, had an excellent domestic macro backdrop. According to the first advance estimates, gross domestic product (GDP) in constant prices is projected to grow 7.4 per cent in the current financial year, against 6.5 per cent in 2024-25.

Domestic sales a booster dose for pharma revenues

Domestic sales a booster dose for pharma revenues

Rediff.com19 Jan 2026

Buoyant domestic sales are expected to lift revenues for pharma companies by 8-11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag. Most brokerages forecast a modest 2-4 per cent growth in profit after tax (PAT) for the quarter. Hospitals and diagnostics companies, meanwhile, are likely to post much stronger numbers, with revenues seen growing 20-22 per cent year-on-year (Y-o-Y).

SAD leader Majithia moves HC against assets case, calls it vendetta

SAD leader Majithia moves HC against assets case, calls it vendetta

Rediff.com2 Jul 2025

The bureau had on June 25 registered an FIR and arrested Majithia in the case allegedly involving laundering of Rs 540 crore of "drug money".

Smallcap To Watch Out For In 2026

Smallcap To Watch Out For In 2026

Rediff.com4 Feb 2026

After two years of strong gains, smallcap stocks fell sharply in 2025, but the correction may be setting up opportunities for long-term investors.

TN govt revokes license for Coldrif cough syrup; shuts down firm

TN govt revokes license for Coldrif cough syrup; shuts down firm

Rediff.com13 Oct 2025

The Enforcement Directorate (ED) raided premises linked to Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup linked to the deaths of children in Madhya Pradesh and Rajasthan, and top officials of the Tamil Nadu FDA as part of a money laundering investigation.

J-K LG sacks two teachers for alleged terror links

J-K LG sacks two teachers for alleged terror links

Rediff.com30 Oct 2025

Jammu and Kashmir Lieutenant Governor Manoj Sinha dismissed two government employees, both teachers, for their alleged links with terrorists. The action is part of Sinha's zero-tolerance policy against terrorism and a broader crackdown on the terror ecosystem within Jammu and Kashmir.

Emcure sets sights on pan-Indian obesity market with Poviztra

Emcure sets sights on pan-Indian obesity market with Poviztra

Rediff.com23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

Putin attends dinner hosted by President Murmu at Rashtrapati Bhavan

Putin attends dinner hosted by President Murmu at Rashtrapati Bhavan

Rediff.com5 Dec 2025

Russian President Vladimir Putin attended dinner hosted in his honour by President Droupadi Murmu at Rashtrapati Bhavan on Friday evening.

Taskaree: The Smuggler's Web Review: A Neeraj Pandey thriller

Taskaree: The Smuggler's Web Review: A Neeraj Pandey thriller

Rediff.com15 Jan 2026

It is difficult to make conveyor belt and baggage-scanning scenes thrilling -- which is how most people trying to sneak out through the Green Channel are caught -- but Neeraj Pandey and co-director Raghav M Jairath and co-writer Vipul K Rawal make sure there is enough going on to make the series watchable, raves Deepa Gahlot.

ED grills Punjab minister in drug money laundering case

ED grills Punjab minister in drug money laundering case

Rediff.com26 Dec 2014

Punjab Revenue Minister Bikram Singh Majithia was on Friday questioned by the Enforcement Directorate in connection with the alleged Rs 6,000 crore money laundering drugs racket case.

'Rhea Took Zero Money From Sushant Singh Rajput'

'Rhea Took Zero Money From Sushant Singh Rajput'

Rediff.com24 Mar 2025

'Sushant Singh Rajput threw Rhea Chakraborty out of his house six days before he died.'

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Dharmendra's Top 10 Action Movies

Dharmendra's Top 10 Action Movies

Rediff.com1 Dec 2025

Dharmendra got his He Man image with Phool Aur Patthar, which was so strong that he never managed to fully shrug it off.

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.

NIA chargesheets 8 in Gujarat narco-terror case linked to Lashkar

NIA chargesheets 8 in Gujarat narco-terror case linked to Lashkar

Rediff.com8 Oct 2025

The National Investigation Agency (NIA) has charge-sheeted eight more individuals in connection with a 2020 transnational narco-terror network case involving the smuggling of drugs from Pakistan to Gujarat, with the aim of financing the Lashkar-e-Taiba (LeT) terror group.

Petro exports to US grew in October as other sectors slide

Petro exports to US grew in October as other sectors slide

Rediff.com8 Dec 2025

India's exports to the US contracted 8.6 per cent to $6.3 billion in October, while imports rose 13.9 per cent to $4.5 billion leading to a trade surplus of $1.8 billion during the month.

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Rediff.com5 Nov 2025

Sun Pharmaceutical Industries on Wednesday posted a 2.56 per cent increase in its consolidated net profit to Rs 3,118 crore for the second quarter ended September 30, aided by robust sales in India and emerging markets. The Mumbai-based drug major reported a net profit of Rs 3,040 crore for the July-September quarter of the last fiscal.

US tariffs: Only Sun Pharma exposed to some headline risk

US tariffs: Only Sun Pharma exposed to some headline risk

Rediff.com28 Sep 2025

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report.

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Rediff.com26 Sep 2025

Most pharma shares dropped, dragging the BSE Healthcare index down by 2.14 per cent after Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1. Wockhardt shares tanked 9.4 per cent.

Bishnoi Gang kills Indian-origin businessman in Canada

Bishnoi Gang kills Indian-origin businessman in Canada

Rediff.com29 Oct 2025

A 68-year-old Indian-origin businessman named Darshan Singh Sahsi was killed in Canada's Abbotsford on Monday morning, reported the Vancouver Sun.

US charges Honduran football club chief with laundering drug money

US charges Honduran football club chief with laundering drug money

Rediff.com8 Oct 2015

The president of a top Honduras football club and two family members were charged by US authorities on Wednesday with engineering a decade-long scheme to launder drug trafficking and foreign bribery proceeds through US accounts.

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

Trump's drug price cut plan may put pressure on India

Trump's drug price cut plan may put pressure on India

Rediff.com12 May 2025

US President Donald Trump's plan to sign an executive order to cut prescription drug prices by 30-80 per cent could lead to a global price adjustment with pharma firms pushing lower-cost countries like India to raise prices, according to the economic think tank GTRI. The US move could push prices in lower-cost countries like India as manufacturers would seek to recover losses and R&D costs from these nations.

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.

Highest Selling New Drug In India Is...

Highest Selling New Drug In India Is...

Rediff.com11 Feb 2025

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Rediff.com12 Apr 2025

Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning trade on the back of an announcement that a court ruling has cleared the deck for the India's largest pharmaceutical company to launch its alopecia drug Leqselvi in the United States.

Strong therapies, JB to lift Torrent Pharma

Strong therapies, JB to lift Torrent Pharma

Rediff.com18 Nov 2025

A strong performance in the July-September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals.

200% spike in gold import drives India's trade deficit to $41.68 billion

200% spike in gold import drives India's trade deficit to $41.68 billion

Rediff.com22 Nov 2025

India's merchandise trade deficit widened to a record $41.68 billion in October, as gold imports trebled and outbound shipments registered their sharpest contraction in 14 months, according to data released by the commerce department.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.